rs9368758
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_080680.3(COL11A2):c.3582+82C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0865 in 1,570,954 control chromosomes in the GnomAD database, including 10,543 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.095 ( 1222 hom., cov: 31)
Exomes 𝑓: 0.086 ( 9321 hom. )
Consequence
COL11A2
NM_080680.3 intron
NM_080680.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.506
Publications
32 publications found
Genes affected
COL11A2 (HGNC:2187): (collagen type XI alpha 2 chain) This gene encodes one of the two alpha chains of type XI collagen, a minor fibrillar collagen. It is located on chromosome 6 very close to but separate from the gene for retinoid X receptor beta. Type XI collagen is a heterotrimer but the third alpha chain is a post-translationally modified alpha 1 type II chain. Proteolytic processing of this type XI chain produces PARP, a proline/arginine-rich protein that is an amino terminal domain. Mutations in this gene are associated with type III Stickler syndrome, otospondylomegaepiphyseal dysplasia (OSMED syndrome), Weissenbacher-Zweymuller syndrome, autosomal dominant non-syndromic sensorineural type 13 deafness (DFNA13), and autosomal recessive non-syndromic sensorineural type 53 deafness (DFNB53). Alternative splicing results in multiple transcript variants. A related pseudogene is located nearby on chromosome 6. [provided by RefSeq, Jul 2009]
COL11A2 Gene-Disease associations (from GenCC):
- autosomal dominant nonsyndromic hearing loss 13Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, LIMITED Submitted by: Ambry Genetics, PanelApp Australia, Labcorp Genetics (formerly Invitae), G2P
- nonsyndromic genetic hearing lossInheritance: AD, AR Classification: DEFINITIVE, MODERATE Submitted by: ClinGen
- otospondylomegaepiphyseal dysplasia, autosomal dominantInheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: PanelApp Australia, Ambry Genetics, Orphanet, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P
- autosomal recessive nonsyndromic hearing loss 53Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: G2P, PanelApp Australia, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- otospondylomegaepiphyseal dysplasiaInheritance: AR, AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- otospondylomegaepiphyseal dysplasia, autosomal recessiveInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: PanelApp Australia, Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
- autosomal dominant nonsyndromic hearing lossInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- fibrochondrogenesisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hearing loss, autosomal recessiveInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 6-33170244-G-A is Benign according to our data. Variant chr6-33170244-G-A is described in ClinVar as Benign. ClinVar VariationId is 1235794.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.494 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| COL11A2 | NM_080680.3 | c.3582+82C>T | intron_variant | Intron 48 of 65 | ENST00000341947.7 | NP_542411.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| COL11A2 | ENST00000341947.7 | c.3582+82C>T | intron_variant | Intron 48 of 65 | 5 | NM_080680.3 | ENSP00000339915.2 | |||
| COL11A2 | ENST00000374708.8 | c.3324+82C>T | intron_variant | Intron 46 of 63 | 5 | ENSP00000363840.4 | ||||
| COL11A2 | ENST00000477772.1 | n.273-4428C>T | intron_variant | Intron 5 of 8 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0948 AC: 14424AN: 152084Hom.: 1211 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
14424
AN:
152084
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0856 AC: 121487AN: 1418752Hom.: 9321 Cov.: 29 AF XY: 0.0846 AC XY: 59845AN XY: 707006 show subpopulations
GnomAD4 exome
AF:
AC:
121487
AN:
1418752
Hom.:
Cov.:
29
AF XY:
AC XY:
59845
AN XY:
707006
show subpopulations
African (AFR)
AF:
AC:
3030
AN:
32422
American (AMR)
AF:
AC:
3317
AN:
42476
Ashkenazi Jewish (ASJ)
AF:
AC:
1199
AN:
25700
East Asian (EAS)
AF:
AC:
20303
AN:
38786
South Asian (SAS)
AF:
AC:
6690
AN:
84354
European-Finnish (FIN)
AF:
AC:
4001
AN:
52216
Middle Eastern (MID)
AF:
AC:
405
AN:
5716
European-Non Finnish (NFE)
AF:
AC:
77103
AN:
1078188
Other (OTH)
AF:
AC:
5439
AN:
58894
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
5973
11947
17920
23894
29867
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
3080
6160
9240
12320
15400
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0949 AC: 14442AN: 152202Hom.: 1222 Cov.: 31 AF XY: 0.0968 AC XY: 7201AN XY: 74404 show subpopulations
GnomAD4 genome
AF:
AC:
14442
AN:
152202
Hom.:
Cov.:
31
AF XY:
AC XY:
7201
AN XY:
74404
show subpopulations
African (AFR)
AF:
AC:
4009
AN:
41500
American (AMR)
AF:
AC:
1286
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
AC:
151
AN:
3472
East Asian (EAS)
AF:
AC:
2629
AN:
5154
South Asian (SAS)
AF:
AC:
422
AN:
4824
European-Finnish (FIN)
AF:
AC:
903
AN:
10610
Middle Eastern (MID)
AF:
AC:
32
AN:
294
European-Non Finnish (NFE)
AF:
AC:
4708
AN:
68020
Other (OTH)
AF:
AC:
254
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
630
1259
1889
2518
3148
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
162
324
486
648
810
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
826
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Jun 24, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.